<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00513201</url>
  </required_header>
  <id_info>
    <org_study_id>Second University of Naples</org_study_id>
    <nct_id>NCT00513201</nct_id>
  </id_info>
  <brief_title>Lyspro Insulin vs Regular Insulin in Cirrhotic Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJECTIVE: To compare lispro insulin and regular insulin in the glycemic control of patients
      with liver cirrhosis and type 2 diabetes subjects. METHODS: 108 patients with liver cirrhosis
      and type 2 diabetes were randomly treated with regular insulin or lispro. After 122 weeks a
      cross-over was carried out and patients followed-up for 122 weeks. Then, all patients
      received a standard breakfast of 145 kcal following 12 U.I. of regular insulin or lispro, and
      C-peptide and insulin serum levels were determined over 300 minutes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control in lyspro vs regular insulin treated patients</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic control in lyspro vs regular insulin in cirrhotic patients</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance to treatment and reduced postprandial hypoglycemia episodes</measure>
  </secondary_outcome>
  <condition>Diabetes Mellitus</condition>
  <condition>Cirrhosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lyspro</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>regular insulin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Insulin-treated diabetes mellitus and liver cirrhosis

        Exclusion Criteria:

          -  Oral hypoglycemic agents treated diabetes mellitus

          -  Liver cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>48 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Roberto Torella, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2007</study_first_submitted>
  <study_first_submitted_qc>August 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2007</study_first_posted>
  <last_update_submitted>August 7, 2007</last_update_submitted>
  <last_update_submitted_qc>August 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2007</last_update_posted>
  <keyword>lyspro</keyword>
  <keyword>regular insulin</keyword>
  <keyword>cirrhotic patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Lispro</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

